Inmode Graham Number
The Graham Number of Inmode (INMD) as of Oct 9, 2026 is 18.85 USD. In the previous year, Graham Number was 24.95 USD — a change of -24.45% (lower).
Get this data via API
Financial Data API
Graham Number
18.85USD
YoY
-24.45%
Last updated:
Graham Number of Inmode is 2025 18.85 USD. Graham Number of Inmode was 2024 24.95 USD. It decreases by -24.45% lower compared to the previous year.
The Inmode Graham Number history
3 Years
10 Years
25 Years
Max
Graham Number
Date
Graham Number
Jan 1, 2018
2.32 USD
Jan 1, 2019
6.78 USD
Jan 1, 2020
8.93 USD
Jan 1, 2021
16.79 USD
Jan 1, 2022
19.19 USD
Jan 1, 2023
25.39 USD
Jan 1, 2024
24.95 USD
Jan 1, 2025
18.85 USD
| YEAR | Graham Number | YoY |
|---|---|---|
| 18.85USD | -24.45% | |
| 24.95USD | -1.74% | |
| 25.39USD | +32.29% | |
| 19.19USD | +14.30% | |
| 16.79USD | +87.96% | |
| 8.93USD | +31.86% | |
| 6.78USD | +192.26% | |
| 2.32USD | +160.38% | |
| 0.89USD | +529.67% | |
| 0.14USD | — |
Access this data via the Eulerpool API
Inmode Stock analysis
What does Inmode do? Inmode Ltd is a leading company in the field of aesthetic medicine, offering innovative technologies used by doctors and beauty clinics around the world to help patients improve their beauty and well-being. The company was founded in 2008 and is headquartered in Yokneam, Israel, with offices in North America, Europe, and Asia. Inmode is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Inmode stock
Graham Number of Inmode is 18.85 USD in 2025.
On Eulerpool you can find the complete historical development of Graham Number Inmode since 2006 – with annual values, charts, and detailed analysis.
The Graham Number estimates the maximum fair price for a stock based on EPS and book value per share, following Benjamin Graham's value investing principles.
Access this data via the Eulerpool API
Quality — Inmode
All Key Metrics — Inmode
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth